Vsee Health, Inc.

Name: Vsee Health, Inc. standardized financial statements, quarterly
Creator: Listed

VSEECIK 1864531HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$1.6m, Q2 FY2026

Operating income−$2.7m, Q2 FY2026

Net income−$1.7m, Q2 FY2026

Vsee Health, Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	1.4	1.5	1.6	1.7	3.4	3.7	3.3	1.1	4.0	3.9	3.2	1.6
Cost of revenue	$m	0.5	0.4	0.4	0.9	0.6	1.4	1.5	0.4	1.9	2.1	2.0	1.4
Gross profit	$m	1.0	1.1	1.2	0.8	2.8	2.4	1.9	0.6	2.1	1.8	1.2	0.2
Operating income	$m	(0.4)	(0.1)	0.1	(0.9)	(58.3)	(3.0)	(1.8)	(1.6)	(2.1)	(3.4)	(3.0)	(2.7)
Interest expense	$m	0.0	0.0	0.0	0.3	0.1	(0.3)	0.0	0.2	0.8	1.1	0.1	0.0
Income tax	$m	(0.2)	2.4	0.0	(1.7)	0.0	0.0	0.0	0.0	0.0	(0.0)	0.0	(0.0)
Net income	$m	(0.2)	(2.5)	0.1	(0.6)	(53.9)	(3.2)	(4.0)	(2.6)	(0.3)	(7.9)	(2.6)	(1.7)
Diluted EPS	$ per share	(0.02)	not reported	0.01	(0.12)	(3.58)	not reported	(0.24)	(0.16)	(0.02)	not reported	(0.05)	not reported
Basic EPS	$ per share	(0.02)	not reported	0.01	(0.12)	(3.58)	not reported	(0.24)	(0.16)	(0.02)	not reported	(0.05)	not reported

Balance sheet

Cash and equivalents$454.2k, Q2 FY2026

Long-term debt$781.6k, Q2 FY2026

Shareholders' equity$7.6m, Q2 FY2026

Vsee Health, Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	0.0	0.1	0.0	1.1	2.3	0.3	0.4	0.3	0.5	5.1	1.3	0.5
Current assets	$m	0.0	0.8	0.0	3.1	4.4	3.0	3.1	2.6	3.7	8.4	4.8	3.3
Total assets	$m	8.1	0.8	1.4	78.6	22.3	20.0	19.4	18.2	18.7	22.4	19.0	16.7
Current liabilities	$m	5.0	5.1	9.0	24.1	20.2	19.0	22.0	23.1	23.4	16.2	11.8	8.1
Total liabilities	$m	5.0	5.1	5.6	25.5	21.4	20.0	22.9	23.9	24.3	17.0	12.7	9.1
Long-term debt	$m	not reported	0.2	not reported	0.6	0.6	0.6	0.6	0.6	0.6	0.6	0.8	0.8
Current portion of debt	$m	not reported	0.2	not reported	0.9	0.4	0.4	1.1	1.5	1.9	0.9	0.5	0.3
Shareholders' equity	$m	(9.1)	(12.3)	(13.2)	53.1	0.9	(0.0)	(3.5)	(5.7)	(5.6)	5.5	6.3	7.6

Cash flow

Operating cash flow−$1.2m, Q2 FY2026

Capital expenditure$73.2k, Q2 FY2026

Share repurchases$0, Q2 FY2026

Vsee Health, Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(48.8)	(109)	579	(3,174)	(221)	(2,974)	(440)	(325)	(755)	(1,926)	(2,452)	(1,174)
Capital expenditure	$k	0.0	1.6	8.7	36.8	5.0	4.8	11.9	(11.9)	22.8	7.2	26.8	73.2
Share repurchases	$k	not reported	not reported	not reported	not reported	not reported	5.2	0.0	0.0	0.0	0.0	50.0	0.0

Diluted shares (weighted)53.66m, Q2 FY2026

Vsee Health, Inc., shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	14.9	4.2	4.6	10.0	4.6	5.3	15.1	16.3	16.4	16.5	47.9	53.7

Shares outstanding: 56.68m at Aug 12, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.